<DOC>
	<DOCNO>NCT00761358</DOCNO>
	<brief_summary>The purpose study verify superior efficacy Z-338 placebo subject Functional Dyspepsia , focus assessment subjective symptom .</brief_summary>
	<brief_title>To Verify Efficacy Z-338 Subjects With Functional Dyspepsia</brief_title>
	<detailed_description />
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<criteria>Subjects show least one 4 symptom ( upper abdominal pain , upper abdominal discomfort , epigastric pain , epigastric burning ) least 6 month obtain informed consent Subjects show two follow symptom : upper abdominal pain , upper abdominal discomfort , postprandial fullness , upper abdominal bloating , early satiety , nausea , vomit and/or excessive belching least 3 month ( one postprandial fullness early satiation ) Bothersome symptoms postprandial fullness , upper abdominal bloat early satiety time obtain informed consent Subjects structural disease likely explain symptom ( e.g. , GERD , erosion , ulcer , hiatal hernia , bleeding , malignancy Barrett 's esophagus ) confirm upper endoscopy obtain informed consent Subjects heartburn last 12 week obtain informed consent Subjects irritable bowel disease ( IBS ) Subjects diabetes mellitus require treatment Subjects serious anxiety disorder Subjects depression and/or sleep disorder Subjects biliary tract disease and/or pancreatitis ( include chronic pancreatitis )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Acotiamide</keyword>
</DOC>